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Abstract
Coagulase-negative staphylococci (CoNS) are frequent contaminants of blood cultures. We aimed to evaluate the systemic inﬂammatory
response syndrome (SIRS) criteria in patients with CoNS bacteraemia for discrimination between true bloodstream infection (BSI) and
contamination. Prospective evaluation was carried out of clinical and laboratory parameters in adults with at least one positive blood
culture with CoNS at the University Hospital of Basel between 2003 and 2007. Of 3060 positive blood cultures, 654 episodes of CoNS
bacteraemia were identiﬁed. Of these, 232 (35%) were considered to be true BSI and 422 (65%) were considered to be contamination.
Overall, 80% of study participants had at least one SIRS criterion, fever being the most common, and 49% had at least two SIRS criteria.
In the multivariate analysis, independent predictors of BSI were fever or hypothermia (OR 2.93, 95% CI 1.91–4.5), tachycardia (OR
2.29, 95% CI 1.50–3.50), tachypnoea (OR 2.4, 95% CI 1.30–4.43), leucocytosis or leucopenia (OR 4.15, 95% CI 2.17–6.36) and the pres-
ence of a central venous line (OR 5.38, 95% CI 3.25–8.88). The probability of BSI increased with each additional SIRS criterion, ranging
from 42.4% in patients with only one SIRS criterion to 56.7% for those with two criteria, and 72.3% for patients with three SIRS crite-
ria. A positive blood culture with CoNS most likely represents true BSI if the patient has at least three SIRS criteria or two SIRS crite-
ria and a central venous catheter. These simple bedside criteria may guide decision to treat, decreasing the use of glycopeptides.
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Introduction
Coagulase-negative staphylococci (CoNS) are among the
most frequently isolated pathogens in blood cultures and an
important cause of nosocomial bloodstream infections (BSI)
[1,2]. As ubiquitous skin commensals, CoNS are also the
most common contaminants of blood cultures [3]. In clinical
practice, it is important to distinguish between contamination
and BSI [4,5] to prevent unnecessary prescription of antimi-
crobial agents leading to a selection of antimicrobial-resistant
organisms such as vancomycin-resistant enterococci [6],
longer hospitalization and increased costs [7,8]. The clinical
relevance of a single blood culture positive for CoNS is difﬁ-
cult to assess, mainly because of the lack of a diagnostic ref-
erence standard for BSI [9]. Contamination is generally
presumed if only one of at least two sets of blood cultures
is positive for CoNS, whereas true BSI is assumed if at least
two blood cultures yield CoNS [10–12]. However, several
studies reported that about one-third of patients with true
BSI had only one positive blood culture [13,14], and that
contamination was possible even if two or more sets were
positive [10,13]. In the literature, various clinical or labora-
tory deﬁnitions have been proposed to determine the clinical
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE BACTERIOLOGY
relevance of bacteraemia [15–20]. Of these, the CDC
deﬁnition of a primary BSI [7] is the most commonly used,
requiring clinical evidence of an infection plus an appropriate
antibiotic therapy if an intravenous catheter is present; or at
least two positive blood cultures. This deﬁnition was found
to have a sensitivity of 67%, speciﬁcity of 56% and a positive
predictive value of 31% [16]. Among laboratory-based
methods, molecular genotyping such as pulsed-ﬁeld gel elec-
trophoresis and evaluation of bioﬁlm-forming properties in
CoNS were investigated as predictors of true BSI [10,21].
However, these laboratory methods are too time-consuming
to guide a rapid start of an appropriate antimicrobial therapy
in case of BSI. Moreover, molecular typing of CoNS from
blood cultures did not seem to correlate with clinical criteria
for BSI.[22] Clinical diagnosis of BSI relies on the presence
of at least two of four systemic inﬂammatory response
syndrome (SIRS) criteria. However, SIRS criteria have not
been validated in the setting of bacteraemia with CoNS [23].
The aim of this study was to evaluate predictors of BSI
and the usefulness of the SIRS criteria in patients with
CoNS bacteraemia to discriminate between true BSI and
contamination.
Methods
Study population and design
All adults with at least one positive blood culture with
CoNS between 1 January 2003 and 31 December 2007 at
the University Hospital Basel were eligible for this study.
We excluded patients with neutropenia (leucocyte count
<4 G/L) and those with growth of at least two different
microorganisms in the same blood culture or in at least
two separate blood cultures within 48 h [24,25]. The Uni-
versity Hospital Basel is a tertiary-care 800-bed teaching
institution serving the northwestern part of Switzerland
with a population of approximately half a million people,
with about 31 000 admissions and >17 000 blood cultures
taken annually. Clinical and laboratory data were prospec-
tively collected by infection control practitioners using a
standardized case report form. Data routinely collected
included demographic characteristics, co-morbidities (diabe-
tes mellitus, immunodeﬁciency, alcohol consumption, inject-
ing drug use), hospital ward and clinical presentation
including temperature, heart and respiratory rate. Immuno-
deﬁciency was deﬁned as immunosuppressive treatment
(immunosuppressant drugs, chemotherapy or prednisone
with a dosage of at least 25 mg daily) or impaired immune
system such as HIV infection. Further predisposing condi-
tions recorded were surgical procedures, invasive ventila-
tion and the presence of devices (i.e. central venous
catheter, arterial catheters or peripheral lines) or implants.
Blood tests included leucocyte count, C-reactive protein
and creatinine. One episode of CoNS bacteraemia was
deﬁned as growth of CoNS in one or more blood cultures
collected within 1 week. Nosocomial infection was deﬁned
as occurrence of BSI with CoNS after more than 48 h of
hospitalization. Only the ﬁrst episode was counted if there
were multiple episodes for the same patient.
Microbiological methods
The identiﬁcation of blood isolates was performed using the
automated BacT/Alert 3D blood culture system (Organon
Teknika Corp., Durham, NC, USA) [26], where samples
were incubated for at least 7 days. Microbiology susceptibil-
ity tests were performed according to CLSI guidelines.
Detection of CoNS relied on non-invasive colorimetric mea-
surement of CO2 produced by growing microorganisms and
was followed by Gram staining and subcultures of positive
samples. The ﬁnal identiﬁcation of isolates was performed by
standard procedures as previously described [27].
Blood stream infection
Diagnosis of BSI was assessed by a Fellow in infectious dis-
eases and conﬁrmed by a board-certiﬁed infectious diseases
specialist in patients with at least one blood culture positive
for CoNS based on the clinical presentation without an
apparent infection at another site. SIRS was diagnosed if at
least two of the following criteria were fulﬁlled: temperature
>38C or <36C; heart rate >90/min; respiratory rate >20/
min; leucocyte count >12 or <4 G/L or >10% immature neu-
trophil granulocytes [23].
Statistical analysis
Basic demographic characteristics, co-morbidities, clinical and
laboratory parameters including SIRS criteria, and antibiotic
therapy were compared according to the presence of BSI as
evaluated by an infectious diseases specialist using the chi-
square test or Fisher’s exact test for categorical variables
and the Mann–Whitney U test for continuous variables.
Logistic regression was used to estimate the predictors of
true BSI in patients with CoNS bacteraemia.
All analyses were performed using STATA software ver-
sion 11 for Windows (Stata Corp., College Station, TX,
USA).
Ethical approval
The study was approved by the local ethical committee as
part of the continuous quality assurance programme of the
University Hospital Basel.
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Results
Study population
A total of 2705 patients had positive blood cultures during
the study period. Among them, we identiﬁed 676 patients
with at least one positive blood culture with CoNS between
2003 and 2007 at the University Hospital Basel. Of these, 22
patients were excluded because of neutropenia. The ﬁnal
analysis was performed on 654 patients. Baseline characteris-
tics are summarized in Table 1.
Predictors of bloodstream infection
Bacteraemia with CoNS was classiﬁed as BSI in 232 patients
(35%) and contamination in 422 patients (65%). CoNS was
isolated in more than one blood culture in 208 patients
(32%), more frequently in case of BSI than contamination
(68% vs. 12%, p <0.001).
Overall, 80% of study participants had at least one SIRS
criterion, fever being the most common, and 49% had at
least two SIRS criteria. Conversely, only 5% of patients
with BSI compared with 29% of those with contamination
(p <0.001) had no SIRS criteria when blood cultures were
taken. BSI was more frequently diagnosed in patients with
an implant or device (23% vs. 15%, p 0.013, Table 1).
Patients with an implant or device were older (p <0.001)
and less frequently injecting drug users (p <0.001), but no
differences in the clinical presentation (SIRS criteria),
C-reactive protein and central venous catheter were noted
between both groups. According to susceptibility tests,
287 (45%) of CoNS isolates were resistant to oxacillin,
more frequently in BSI (55% vs. 40%, p <0.001). Among
313 (48%) patients started on antibiotic treatment (b-lac-
tam antibiotics or vancomycin), 161 had true BSI and 152
had contamination with CoNS, corresponding to a treat-
ment rate of 69% for BSI and 36% for contamination
(p <0.001). Compared with patients with contamination
due to CoNS, those with BSI remained in hospital longer
(median duration of 22 days, interquartile range (IQR) 11–
39 days vs. 13 days, 6–24 days, p <0.001) and in the inten-
sive-care unit (median stay of 9 days, IQR 4–21 days vs.
6 days, IQR 3–11, p <0.001). Death from all causes
occurred more frequently in patients with true CoNS BSI
compared with those with contamination (18% vs. 9%,
p 0.001).
Predictors of BSI (Table 2) in univariate analysis were an
increasing number of positive blood cultures, central venous
catheter, stay in a surgery ward or intensive-care unit,
invasive ventilation, carrying an implant or device, SIRS crite-
ria and C-reactive protein. In multivariate analysis, a single
blood culture positive for CoNS was likely to represent BSI
if a central venous line (OR 5.38, 95% CI 3.25–8.88), fever
or hypothermia (OR 2.93, 95% CI 1.91–4.5), tachycardia
(OR 2.29, 95% CI 1.50–3.50), tachypnoea (OR 2.4, 95% CI
1.30–4.43) and leucocytosis or leucopenia (OR 4.15, 95% CI
2.17–6.36) were present.
TABLE 1. Baseline characteristics
of the study population (n = 654)
according to the clinical relevance
of one single blood culture positive
for coagulase-negative staphylo-
cocci
Characteristic
Bloodstream infection (n = 232) Contamination (n = 422)
p valuen (%)a n (%)a
Median age, IQR 65 (49–74) 65 (49–75) 0.427
Male gender 140 (60) 274 (59) 0.652
Diabetes mellitus 45 (19) 77 (18) 0.718
Alcohol use 32 (14) 40 (9) 0.092
Intravenous drug use 17 (7) 30 (7) 0.918
HIV infection 8 (3) 11 (3) 0.540
Immunodeﬁciency 36 (16) 71 (17) 0.665
Treatment with corticosteroids 6 (3) 17 (4) 0.338
Ward
Emergency room 43 (27) 114 (73) 0.005
Surgery 54 (45) 66 (55)
Intensive-care unit 65 (41) 93 (59)
Medicine 70 (32) 149 (68)
Central venous catheter 153 (67) 121 (31) <0.001
Implant or device 54 (23) 65 (15) 0.013
Artiﬁcial invasive ventilation 107 (46) 107 (25) <0.001
Fever (>38C) or hypothermia (<36C) 154 (66) 157 (37) <0.001
Heart rate >90/min 145 (63) 145 (34) <0.001
Respiratory rate >20/min 52 (22) 35 (8) <0.001
Leucocytes >12 or <4 G/L 154 (66) 142 (34) <0.001
Median C-reactive protein, IQR (mg/L) 118 (58–196) 81 (31–147) <0.001
Median number of positive blood cultures
within 1 week, IQR
2 (1–4) 1 (1–2) <0.001
Median number of blood cultures taken
within 1 week, IQR
6 (4–8) 4 (4–8) <0.001
a Data given as n (%) except where indicated as median (IQR; interquartile range).
b Bold values indicate p values that are statistically signiﬁcant (i.e. below 0.05).
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Algorithm to determine the clinical relevance of a single
positive blood culture with CoNS
The probability of BSI increased with each additional SIRS
criterion (test for trend p <0.001), ranging from 42.4% in
patients with only one SIRS criterion to 82.6% for those with
four SIRS criteria. Among patients with two SIRS criteria, the
positive predictive value of BSI increased from 56.7% to
73.4% if there was a central venous catheter (Table 3).
The algorithm with the best combined sensitivity and
speciﬁcity for CoNS BSI was deﬁned as at least two positive
blood cultures within 7 days, or one single positive blood
culture plus at least two SIRS criteria and a central venous
catheter, or one positive blood culture and three SIRS
criteria (Fig. 1).
Discussion
This study, involving 654 patients with CoNS bacteraemia,
indicates that a single blood culture positive for CoNS is
likely to represent BSI if at least three SIRS criteria or two
SIRS criteria and a central venous catheter are present.
These ﬁndings are consistent with previous studies, where a
positive blood culture and a clinical picture compatible with
infection had a similar positive predictive value as at least
two positive blood cultures [4,16,28]. However, this is, to
our knowledge, the ﬁrst study assessing the clinical signiﬁ-
cance of CoNS bacteraemia using the SIRS criteria.
We have proposed an algorithm that can be easily used
by clinicians to determine the clinical signiﬁcance of CoNS
isolated from blood cultures. Although only 36% of CoNS
bacteraemias were deﬁned as true BSI in our study, up to
50% of the study population fulﬁlled the deﬁnition of SIRS,
which is deﬁned as the presence of at least three SIRS crite-
ria. The SIRS deﬁnition was therefore too sensitive and non-
speciﬁc for bedside prediction of a BSI. This ﬁnding is in line
with previous studies [29,30]. An antimicrobial therapy based
only on the deﬁnition of SIRS would therefore lead to an
overestimation of true BSI and to unnecessary prescription
of antibiotics. This is particularly important in the setting of
CoNS bacteraemia, which is considered to be a contamina-
tion on many occasions, and in regions where most CoNS
TABLE 2. Predictors of bloodstream infection, univariate and multivariate OR
Characteristic
Univariate analysis Multivariate analysis
OR 95% CI p value ORa 95% CI p value
Age, per 10 years increase 0.97 0.88–1.06 0.471 1.04 0.91–1.19 0.555
Female gender 0.73 0.67–1.29 0.652 1.08 0.70–1.66 0.735
Diabetes mellitus 1.08 0.72–1.62 0.718 0.88 0.52–1.50 0.640
Alcohol use 1.53 0.93–2.51 0.093 0.46 0.74–2.86 0.275
Intravenous drug use 1.03 0.56–1.92 0.918 0.89 0.38–2.09 0.784
Immunodeﬁciency 0.91 0.56–1.41 0.666 0.65 0.37–1.15 0.140
Ward
Emergency room 1b – – 1b – –
Surgery 2.17 1.31–3.58 0.003 1.14 0.56–2.32 0.720
Intensive-care unit 1.85 1.15–2.97 0.011 0.57 0.26–1.25 0.159
Medicine 1.25 0.79–1.96 0.340 0.91 0.52–1.60 0.740
Central venous catheter 4.52 3.19–6.39 <0.001 5.38 3.25–8.88 <0.001
Device or implant 1.67 1.11–2.49 0.013 1.49 0.89–2.52 0.129
Artiﬁcial ventilation 2.52 1.80–3.54 <0.001 1.14 0.62–2.11 0.674
Fever (>38C) or hypothermia (<36C) 3.33 2.38–4.67 <0.001 2.93 1.91–4.50 <0.001
Heart rate >90/min 3.18 2.28–4.44 <0.001 2.29 1.50–3.50 <0.001
Respiratory rate >20/min 3.19 2.01–5.08 <0.001 2.40 1.30–4.43 0.005
Leucocytes >12 or <4 G/L 3.89 2.77–5.46 <0.001 4.15 2.71–6.36 <0.001
C-reactive protein, per 50 mg/L increase 1.19 1.08–1.30 <0.001 0.99 0.89–1.10 0.828
aAdjusted for all variables listed in the Table.
bReference.
TABLE 3. Validity of a single positive blood culture for coagulase-negative staphylococcis as true bloodstream infection
according to different diagnostic settings
Setting Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
‡1 SIRS criterion 95.3% 28.9% 42.4% 91.7% 52.4%
‡2 SIRS criteria 78.0% 67.3% 56.7% 84.8% 71.1%
‡3 SIRS criteria 36.2% 91.2% 69.4% 72.2% 71.7%
4 SIRS criteria 8.2% 99.1% 82.6% 66.2% 66.8%
‡1 SIRS criterion and a CVC 63.9% 77.5% 62.2% 78.7% 72.5%
‡2 SIRS criteria and a CVC 51.7% 89.1% 73.4% 76.1% 75.4%
‡3 SIRS criteria and a CVC 25.6% 96.9% 83.0% 69.2% 70.8%
CVC, central venous catheter; NPV, negative predictive value; PVP, positive predictive value; SIRS, systemic inﬂammatory response syndrome.
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isolates are resistant to methicillin, leading to an increased
use of vancomycin and therefore to a selection of multiresis-
tant bacteria. The positive predictive value of BSI in patients
with only one SIRS criterion was too low (42.4%), but
increased with each additional SIRS criterion to a maximum
of 82.6% in patients who had four criteria. However, in our
study, only a small proportion of patients with BSI presented
with at least three SIRS criteria (28%) or four SIRS criteria
(26%), indicating that an algorithm to identify true BSI due to
CoNS should include also patients with only two SIRS crite-
ria. When a central venous catheter was present, higher
positive predictive value and accuracy were achieved. The
algorithm with the best combined sensitivity and speciﬁcity
for determining the clinical signiﬁcance of CoNS was deﬁned
as at least two positive blood cultures, or one single positive
blood culture and at least three SIRS criteria, or one single
positive blood culture and at least two SIRS criteria and a
central venous catheter.
In the literature, CoNS bacteraemias are reported to be
highly associated with the use of intravascular devices
[16,31–35], representing 30–60% of all catheter-related BSI
[7,36]. These ﬁndings were supported by our results where
the probability of BSI increased signiﬁcantly among patients
with two SIRS criteria in the presence of a central venous
catheter and showed the highest positive predictive value for
the deﬁnition of a BSI with CoNS. The type of positive SIRS
criterion, however, was not useful in discriminating between
BSI and contamination.
The overall prevalence of true BSI with CoNS was
slightly higher than that reported in the literature, ranging
from 10–12% to 20–30% [4,9,13,15,16,37]. Within our
institution the occurrence of BSI with CoNS varied among dif-
ferent wards ranging from 27–32% in emergency and medical
wards to 41–45% in the intensive-care unit and surgery wards.
However, in multivariate analysis, after adjustment for the
presence of a central venous line, these differences
disappeared, indicating that central venous catheters were
more frequently used in above-mentioned wards and
were the main cause of CoNS BSI. Among other factors,
demographic characteristics, co-morbidities, and the use of
antibiotics did not vary between BSI and contamination.
We acknowledge some limitations. The lack of a reference
standard to diagnose BSI with CoNS made it possible that
misclassiﬁcation of CoNS BSI had occurred during
CoNS isolated from ш 1 blood culture 
Check for SIRS criteria:
Temperature >38°C or <36°C
Heart rate >90/min.
Respiratory rate >20/min.
Leucocyte count >12 or <4 G/L
or >10% immature neutrophils
Is a CVC present?
Yes No
Only 1 posiƟve
blood culture
ш 2 SIRS
criteria 
Probable true BSI with CoNS:
Consider treatment
<2 SIRS
criteria
ш 2 posiƟve blood
cultures in 7-day period 
Probable contaminaƟon
with CoNS
Only 1 posiƟve
blood culture
Probable contaminaƟon
with CoNS
ш 3 SIRS
criteria 
< 3 SIRS
criteria
FIG. 1. Algorithm to evaluate the clinical signiﬁcance of a single blood culture positive for coagulase-negative staphylococci (CoNS) based on
the presence of a central venous catheter (CVC) and systemic inﬂammatory response syndrome (SIRS) criteria.
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assessment of the clinical relevance of CoNS bacteraemia.
However, this evaluation was consistently conﬁrmed by an
experienced infectious diseases specialist based on the clini-
cal presentation and the lack of other infectious foci.
Another limitation was the heterogeneity of patients regard-
ing their underlying diseases and the cause of febrile
episodes. Moreover, assessment of SIRS criteria might have
presented some difﬁculties. For example, fever in patients
already treated with antipyretic agents such as non-steroidal
antirheumatics or steroids, and tachycardia in those treated
with b-adrenergic blocking agents may be absent, leading to
under-reporting of SIRS criteria. In contrast, tachypnoea in
patients with heart failure or concomitant pneumonia might
have overestimated the number of SIRS criteria. In addition,
information on whether blood cultures were drawn from a
central venous catheter was not available for this study.
Moreover, we did not collect the time to positivity for
CoNS bacteraemia. However, the scope of our study was
the clinical assessment of true CoNS BSI and the evaluation
of SIRS criteria. Finally, our algorithm was based on patients
from a single hospital and results of this study may not be
applicable to other populations, i.e. children and neutropenic
patients.
Strengths of this study include the large sample size with
654 non-neutropenic patients presenting with at least one
positive blood culture for CoNS. This is, to our knowledge,
the ﬁrst study focusing on SIRS criteria to discriminate
between BSI and contamination. Our algorithm for the deﬁ-
nition of a true BSI with CoNS represents an accurate and
easy tool for clinicians to select those patients who require
antibiotic treatment and catheter removal. In contrast to
other studies, we included patients from different wards such
as medical and surgical wards, emergency room and inten-
sive-care units, allowing comparison within our hospital.
Conclusions
A positive blood culture with CoNS is likely to represent
BSI if the patient has at least three SIRS criteria or two SIRS
criteria and a central venous catheter. These ﬁndings may
help clinicians to recognize true BSI in patients with a single
positive blood culture with CoNS, providing an indication for
starting adequate treatment.
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